Aethlon Medical Posts Q1 FY2027 Net Loss of $1.55M; Cash Runway Extended to 12 Months
AEMD is trading near its 52-week low of $2.625 (13% above the low) on light trading volume (0.1× avg).
Summary
Aethlon Medical reported a narrower Q1 FY2027 net loss of $1.55 million and extended its cash runway to at least twelve months, supported by ATM sales and a $4.0 million July offering.
Key Events · Earnings and Guidance · AEMD
-
Q1 FY2027 Net Loss Narrows
Net loss of $1,547,912 for the three months ended June 30, 2026, down from $1,761,858 in the prior-year period, driven by lower professional fees and G&A expenses.
-
ATM Sales Add $1.82M Net Proceeds
The company sold 160,028 shares under its at-the-market program, generating gross proceeds of $1,904,000 and net proceeds of $1,821,000 for working capital.
-
Cash Runway Extended to 12 Months
Management states that cash of $4.93 million as of June 30, 2026, plus proceeds from the July 2026 offering, will fund operations for at least twelve months, alleviating the prior going-concern doubt.
-
July 2026 Offering Completed
Subsequent to quarter end, the company completed a registered best-efforts offering of common stock and warrants, generating gross proceeds of approximately $4.0 million.
Analysis · AEMD · Industrial Applications And Services
First-quarter fiscal 2027 results show a net loss of $1.55 million, a 12% improvement from the prior-year period, while the company raised $1.82 million in net proceeds through its ATM program. Management states that cash on hand plus the $4.0 million July 2026 offering proceeds are sufficient to fund operations for at least twelve months, removing the near-term going-concern overhang that had been flagged in the prior 10-K. The reverse stock split and subsequent offering are also disclosed, providing clarity on the company's capital structure.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 29.1% of the 1524 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AEMD was trading at $2.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $2.63 to $137.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.